The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
Part of paid clinical trials in Rochester, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT07561034
- Status
- Recruiting
Conditions
- Interstitial Lung Disease
- Pulmonary Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Home Exercise Program, Aerobic Plus Strength Training — BEHAVIORALStructured home based exercise program delivered by daily SMS text message or email for 16 weeks, including aerobic and strength training activities with heart rate guidance.
- Home Exercise Program, Aerobic Only — BEHAVIORALStructured home based exercise program delivered by daily SMS text message or email for 16 weeks, including aerobic activities with heart rate guidance.
Study Details
This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. Participants will complete a defined exercise regimen over a 16-week period, and functional capacity and patient reported outcomes will be assessed at baseline and after the intervention. The study aims to determine whether a home-based exercise approach is feasible and associated with improvements in functional performance.
Key Dates
- First listed
- May 1, 2026
- Start date
- Jul 15, 2026
- Status verified
- Apr 2026
- Primary completion
- May 30, 2027
- Completion
- May 30, 2027
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Aerobic Plus Strength TrainingParticipants receive 16 weeks of structured daily exercise messages for aerobic and strength training activities with heart rate guidance. Participants also receive resistance bands and ankle weights.
- Active Comparator: Aerobic onlyParticipants receive 16 weeks of structured daily aerobic exercise messages with heart rate guidance. Participants may perform walking or Cubii-based aerobic exercise.
Primary Outcome Measure
Mean Change in Cardiac Effort From Baseline to 16 Weeks [ Time Frame: Baseline to 16 weeks ]
Central Contacts
- Daniel Lachant, DO585 273 4608
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Rochester Medical Center | Rochester | New York | 14642 | Daniel Lachant, DO (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, NY
By research site
Related Studies
- WTC Chest CT Imaging ArchiveEnrolling By Invitation · Icahn School of Medicine at Mount Sinai · New York, New York
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pulmonary Hypertension Association RegistryRecruiting · Pulmonary Hypertension Association, Inc. · Phoenix, Arizona
- Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension SystemRecruiting · Aria CV, Inc · Los Angeles, California